Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer

NCT05806918 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

DRUG: Recombinant Human Interferon α-2b Gel (After the Alteration)
DRUG: Recombinant Human Interferon α-2b Gel (Before the Alteration)

Sponsor

Lee's Pharmaceutical Limited